Drug-binding properties of rat alpha-foetoprotein. Specificities of the phenylbutazone-binding and warfarin-binding sites.
Rat alpha-foetoprotein (alpha-FP) strongly binds the drugs warfarin and phenylbutazone, as does albumin; however, the binding sites for the two drugs seemed to be different. This possibility and the specificity of this/these drug-binding site(s) of rat alpha-FP were investigated by competitive protein-binding experiments with a variety of drugs, representing different pharmacological groups, and biomolecules that are strongly bound by the foetal protein and that are suspected to play a specific role during foetal development. The binding mechanisms were further investigated by using comparisons between computer-derived theoretical displacement curves and experimental points in order to distinguish different possible binding models. The results indicate: that warfarin and phenylbutazone are bound at two distinct sites on rat alpha-FP and that a negative modulatory effect is exerted between the two sites; that the degree of specificity of these two drug-binding sites is different, since the warfarin-binding site appears to be specific for the binding of coumarinic and anthranilic drugs whereas that for phenylbutazone is able to bind substances of very varied chemical structure and is more hydrophobic; that the phenylbutazone-binding site is the site that binds oestrogens that thyroid hormones and, probably, fatty acids and bilirubin are bound at (an)other site(s) but exert negative modulatory effects on phenylbutazone binding. The nature of the different binding areas of rat alpha-FP is compared with that of those already proposed for albumin. The potential risks of toxicity of such interactions between drugs and/or biomolecules on foetal development are also discussed.
D000818:Animals; D001663:Bilirubin / Q000378:metabolism; D001665:Binding Sites; D001667:Binding, Competitive; D004958:Estradiol / Q000378:metabolism; D005227:Fatty Acids / Q000378:metabolism; D008024:Ligands; D010653:Phenylbutazone / Q000378:metabolism*; D011485:Protein Binding; D051381:Rats; D013974:Thyroxine / Q000378:metabolism; D014859:Warfarin / Q000378:metabolism*; D000509:alpha-Fetoproteins / Q000378:metabolism*
D005227:Fatty Acids; D008024:Ligands; D000509:alpha-Fetoproteins; D004958:Estradiol; D014859:Warfarin; D010653:Phenylbutazone; D013974:Thyroxine; D001663:Bilirubin